Combined antipsychotic treatment involving clozapine and aripiprazole

Combined antipsychotic treatment involving clozapine and aripiprazole,10.1016/j.pnpbp.2008.02.010,Progress in Neuro-psychopharmacology & Biological Ps

Combined antipsychotic treatment involving clozapine and aripiprazole   (Citations: 8)
BibTex | RIS | RefWorks Download
Treatment resistance is considered a challenging problem of antipsychotic pharmacotherapy. In such cases, combination approaches are commonly used, for instance the add-on of aripiprazole to clozapine. This review aims at giving an overview of the present knowledge on this strategy.We performed a keyword-based screening of databases (including November 2007) and evaluated the data in a systematic manner.The courses of 94 patients were reported in 11 publications. At a mean dosage of 20.5 mg/day, aripiprazole achieved clinical improvement of psychotic symptoms and facilitated a dose reduction of clozapine from 476.7 to 425.1 mg/day. In parallel, clozapine serum levels decreased from 611 to 523 ng/ml. No pharmacokinetic interactions were reported, and clozapine-induced side effects ameliorated. However, single cases of extrapyramidal side effects occurred.The combination of clozapine and aripiprazole follows a neurobiological rationale and appears to be effective and tolerable. The results of placebo-controlled trials might allow further insight into the benefits and risks of this strategy.
Cumulative Annual
View Publication
The following links allow you to view full publications. These links are maintained by other sources not affiliated with Microsoft Academic Search.
Sort by: